Phase II Study of Trilaciclib, Pembrolizumab, Gemcitabine, and Carboplatin for Advanced Triple-Negative Breast Cancer | Clinical Trial

Phase II Study of Trilaciclib, Pembrolizumab, Gemcitabine, and Carboplatin for Advanced Triple-Negative Breast Cancer | Clinical Trial | Right2Hope